Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Income from Non-Controlling Interests (2016 - 2018)

IGC Pharma has reported Income from Non-Controlling Interests over the past 9 years, most recently at $634.0 for Q1 2018.

  • Quarterly Income from Non-Controlling Interests rose 105.09% to $634.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $320.0 through Jun 2018, down 98.42% year-over-year, with the annual reading at $14399.0 for FY2017, 156.02% up from the prior year.
  • Income from Non-Controlling Interests was $634.0 for Q1 2018 at IGC Pharma, up from -$230.0 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $38088.0 in Q4 2016 and troughed at -$42000.0 in Q4 2015.
  • The 5-year median for Income from Non-Controlling Interests is -$5073.0 (2016), against an average of -$3364.4.
  • Year-over-year, Income from Non-Controlling Interests crashed 15820.44% in 2014 and then skyrocketed 450.89% in 2015.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at -$8882.0 in 2014, then crashed by 372.87% to -$42000.0 in 2015, then skyrocketed by 190.69% to $38088.0 in 2016, then crashed by 100.6% to -$230.0 in 2017, then soared by 375.65% to $634.0 in 2018.
  • Per Business Quant, the three most recent readings for IGC's Income from Non-Controlling Interests are $634.0 (Q1 2018), -$230.0 (Q4 2017), and -$84.0 (Q3 2017).